Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer’s disease ; volume:39 ; number:7 ; day:16 ; month:8 ; year:2024 ; pages:1433-1445 ; date:10.2024
Metabolic brain disease ; 39, Heft 7 (16.8.2024), 1433-1445, 10.2024
- Creator
-
Zhu, Xiangzhen
Gao, Jingfang
Qiu, Chao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11011-024-01409-5
- URN
-
urn:nbn:de:101:1-2501172114439.123901151499
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Xiangzhen
- Gao, Jingfang
- Qiu, Chao
- SpringerLink (Online service)
Other Objects (12)
Alzheimer disease : therapeutic strategies
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
Therapeutic implications of necroptosis activation in Alzheimer´s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Alzheimer disease : therapeutic strategies
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
Therapeutic implications of necroptosis activation in Alzheimer´s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
ApoE4: an emerging therapeutic target for Alzheimer’s disease
Alzheimer disease : therapeutic strategies
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer’s disease
Rho GTPases as therapeutic targets in Alzheimer’s disease
Therapeutic implications of necroptosis activation in Alzheimer´s disease
DUBs in Alzheimer’s disease: mechanisms and therapeutic implications
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Therapeutic potential of APP antisense oligonucleotides for Alzheimer’s disease and down syndrome-related Alzheimer’s disease
Initial Aβ seeds as therapeutic target for Alzheimer’s disease
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease